Plunkett Research Online: ImmunoGen Inc

IMMUNOGEN INC (Subsidiary) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Immunogen, Inc. is a clinical-stage biotechnology company from the United States. Its focus is targeting cancer cells. Immunogen offers the product ELAHERE, which is used to treat adults with folate receptor-alpha positive ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. Immunoge.....


IMMUNOGEN INC

Ticker: Subsidiary
Exchange:
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 781 895-0600
Fax:
Address: 830 Winter St.
Waltham, MA 02451 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:
Parent Company: AbbVie Inc

Contacts Description

Mark EnyedyCEO/Pres.
Lauren WhiteCFO
See More
Immunogen, Inc. is a clinical-stage biotechnology company from the United States. Its focus is targeting cancer cells. Immunogen offers the product ELAHERE, which is used to treat adults with folate receptor-alpha positive ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. Immunoge.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture

The company offers its employees health and dental coverage, life and AD&D insurance, a 401(k) plan, tuition reimbursement and stock options.